HIV-1 superinfection is not a common event.

Pubmed ID: 16036183

Journal: Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology

Publication Date: Aug. 1, 2005

MeSH Terms: Humans, HIV Infections, HIV-1, Substance Abuse, Intravenous, Superinfection, Brazil, Gene Products, tat, Heteroduplex Analysis, tat Gene Products, Human Immunodeficiency Virus

Grants: N01-HB-42972

Authors: Busch MP, Operskalski EA, Mosley JW, Diaz RS, Pardini R, Catroxo M

Cite As: Diaz RS, Pardini R, Catroxo M, Operskalski EA, Mosley JW, Busch MP. HIV-1 superinfection is not a common event. J Clin Virol 2005 Aug;33(4):328-30.

Studies:

Abstract

Evidence for human immunodeficiency virus type 1 (HIV-1) superinfection was investigated among a group of four previously HIV-1 infected transfusion recipients (and the four implicated HIV-1 infected donors) identified by the Transfusion Safety Study, and two groups of 4 and 5 Brazilian injection drug users, who consistently injected themselves using shared paraphernalia. To probe these cases for possible superinfection we used heteroduplex mobility analysis (HMA) of HIV-1 tat, a technique which is a reliable for establishing epidemiologic linkages and searching for minor strains in mixed infection settings. In all these cases with established, untreated HIV-1 infections, we were unable to detect HIV-1 superinfection, even though the involved individuals were at high risk for second strain acquisition. We therefore conclude that although superinfection can occur in a few cases, it is a rare event, and the vast majority of recombinant HIV-1s characterized to date resulted from acute coinfections, rather than superinfection.